Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.

News Rooms

Syngene announces second year of STEM scholarship and mentorship program for women in collaboration with RICH
18th Jun, 2024
Syngene launches platform for rapid, enhanced protein production
4th Jun, 2024
Syngene reports full year and fourth quarter results
24th Apr, 2024
Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
14th Mar, 2024
Syngene reports third quarter results
25th Jan, 2024
Syngene named one of India’s Best Managed Companies by Deloitte
15th Jan, 2024
Syngene International announces the winners of the 2nd edition of the Annual Science Quiz held in Bangalore and Dakshin Kannada
11th Dec, 2023
Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd
1st Dec, 2023
Syngene reports strong second quarter results
17th Oct, 2023
Syngene purchases land to expand operations in Genome Valley, Hyderabad
14th Sep, 2023
Q1 FY24 revenue up 26%, PAT up 26%
25th Jul, 2023
Syngene to acquire multi-model facility from Stelis Biopharma Ltd
2nd Jul, 2023
Sustained positive performance in fourth quarter delivers strong full year results
24th Apr, 2023
Syngene reports strong third quarter results
23rd Jan, 2023
Syngene and the Research and Innovation Circle of Hyderabad (RICH) launch scholarship program for women studying STEM subjects
9th Nov, 2022
Syngene reports second quarter results Revenue from operations up 26% to Rs. 768 crores, PAT increased 11% to Rs.102 crores
19th Oct, 2022
Syngene reports revenue from operations up 8% in the first quarter
20th Jul, 2022
Syngene signs 10-year biologics manufacturing agreement with leading animal health company, Zoetis
14th Jul, 2022
Syngene reports full year revenue from operations up 19% to Rs. 2604 Cr
27th Apr, 2022
Syngene International takes top honors at CMO Leadership Awards 2022 for contract manufacturing
9th Mar, 2022

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details